CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Shares withheld for taxes SVP, HEAD - ESTABLISHED BRANDS gave up 582 shares (to pay taxes)
- 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 2,657 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 7,799 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GENERICS gave up 2,593 shares (to pay taxes)
- 4 Grant or award SVP - CORP. DEV. & STRATEGY acquired 23,936 shares (grant or award)
- 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 1,196 shares (to pay taxes)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $59.54 ($23,816)
- 4 Shares withheld for taxes SVP & CFO gave up 1,730 shares (to pay taxes)
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $53.92 ($21,568)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale SVP & CFO sold 7,500 shares at $55.79 ($418,425)
- 144 Insider Sale of Securities
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $56.24 ($14,060)
- 4 Planned sale SVP, CHIEF HR OFFICER sold 1,000 shares at $60.00 ($60,000)
- 4 Open-market sale PRESIDENT & CEO sold 33,481 shares at an average $57.99 ($1,941,442)
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes SVP, HEAD - ESTABLISHED BRANDS gave up 867 shares (to pay taxes)
Page 12 of 90 · 1,784 filings